Neeraj Kohli

发表

Development of disulfide-stabilized Fabs for targeting of antibody-directed nanotherapeutics

A. Lugovskoy, D. Drummond, D. Kirpotin, 2022, mAbs.

Antibody Co-Administration Can Improve Systemic and Local Distribution of Antibody–Drug Conjugates to Increase In Vivo Efficacy

Greg M. Thurber, J. Pinkas, Y. Setiady, 2020, Molecular Cancer Therapeutics.

Sickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment

L. Hsu, K. Ominu-Evbota, B. Inusa, 2019, International journal of neonatal screening.

MM-141, an IGF-IR– and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors

B. Schoeberl, U. Nielsen, J. Fitzgerald, 2013, Molecular Cancer Therapeutics.

Optimizing properties of antireceptor antibodies using kinetic computational models and experiments.

B. Schoeberl, U. Nielsen, B. Harms, 2012, Methods in enzymology.

MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM

B. Schoeberl, U. Nielsen, A. Raue, 2019, Proceedings of the National Academy of Sciences.

Antibody-mediated targeting of TNFR2 activates CD8+ T cells in mice and promotes antitumor immunity

M. Muda, A. Raue, E. Tam, 2019, Science Translational Medicine.

Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic

U. Nielsen, J. Fitzgerald, O. Burenkova, 2015, Molecular Cancer Therapeutics.

Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor–PI3K Axis

V. Grantcharova, B. Schoeberl, U. Nielsen, 2009, Science Signaling.

Biomimetic interfaces for a multifunctional biosensor array microsystem

A. Mason, J. Zeikus, R. Worden, 2004, Proceedings of IEEE Sensors, 2004..

Improving the developability of an anti-EphA2 single-chain variable fragment for nanoparticle targeting

J. Marks, A. Lugovskoy, Y. Jiao, 2017, mAbs.

Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3

Ulrik B. Nielsen, Birgit Schoeberl, Bo Zhang, 2012, Molecular Cancer Therapeutics.

MM-111: a novel bispecific antibody targeting ErbB3 with potent anti-tumor activity in ErbB2 over-expressing malignancies.

B. Schoeberl, U. Nielsen, B. Harms, 2009 .

Challenging immunosuppression treatment in lung transplant recipients with kidney failure.

M. Carby, H. Lyster, A. Simon, 2016, Transplant Immunology.

Arrays of lipid bilayers and liposomes on patterned polyelectrolyte templates.

R. Worden, R. Ofoli, I. Lee, 2006, Journal of colloid and interface science.

Title: MM-141, an IGF-1R and ErbB3 directed bispecific antibody, overcomes network adaptations that limit activity of IGF-1R inhibitors

B. Schoeberl, U. Nielsen, J. Fitzgerald, 2013 .

Rapid optimization and prototyping for therapeutic antibody-like molecules

B. Schoeberl, U. Nielsen, J. Fitzgerald, 2013, mAbs.

Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models

W. Kamoun, J. Marks, A. Lugovskoy, 2019, Nature Biomedical Engineering.

Novel HPLC-Based Screening Method to Assess Developability of Antibody-Like Molecules.

N. Kohli, Melissa L. Geddie, Neeraj Kohli, 2017, Methods in molecular biology.

A novel screening method to assess developability of antibody-like molecules

Melissa L Geddie, A. Lugovskoy, M. Razlog, 2015, mAbs.

Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models

W. Kamoun, J. Marks, A. Lugovskoy, 2019, Nature Biomedical Engineering.

Comprehensive optimization of a single-chain variable domain antibody fragment as a targeting ligand for a cytotoxic nanoparticle

U. Nielsen, A. Lugovskoy, Y. Jiao, 2015, mAbs.

Direct transfer of preformed patterned bio-nanocomposite films on polyelectrolyte multilayer templates.

R. Worden, I. Lee, Neeraj Kohli, 2007, Macromolecular bioscience.